- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.06. | Roche develops Bundibugyo Ebola test in six days | ||
| 05.06. | First human trial backs AI-designed 'universal' vaccine | ||
| 05.06. | Parabilis prices IPO at an ambitious $475 million | ||
| 04.06. | SCOTUS backs generic firm Hikma in skinny label dispute | ||
| 04.06. | ADC Therapeutics slumps on cancer drug safety scare | ||
| 04.06. | Meet Dalton, a new AI-powered drug discovery platform | ||
| 04.06. | EULAR 26 hears of treatment advances in lupus | ||
| 04.06. | £600m funding call opens for UK biomedical research centres | ||
| 04.06. | AbbVie's ovarian cancer drug Elahere gets NHS green light | ||
| 04.06. | NewLimit raises $435m for liver trials, and other financings | ||
| 03.06. | Lilly strikes $1.9bn kidney disease alliance with Ascidian | ||
| 03.06. | ASCO26: Celcuity punished as trial disappoints investors | ||
| 03.06. | FDA prior knowledge guide seeks to speed cell, gene therapy | ||
| 03.06. | ASCO26: In vivo CAR-Ts in the spotlight | ||
| 02.06. | ASCO26: After negative adcomm, AZ builds case for oral SERD | ||
| 02.06. | Abivax slides on phase 3 data in ulcerative colitis | ||
| 02.06. | ASCO26: Symptom-tracking app helps advanced cancer patients | ||
| 02.06. | ASCO26: AZ triplet makes waves in frontline liver cancer | ||
| 01.06. | CEPI puts $60m behind three Ebola vaccine candidates | ||
| 01.06. | Servier wagers $2.65bn on Edgewise muscular dystrophy drug | ||
| 01.06. | ASCO26: Verzenio gives hope of liposarcoma treatment advance | ||
| 01.06. | DHSC lauds benefits of single patient record ahead of debate | ||
| 01.06. | ASCO26: Could AL amyloidosis see a new crop of therapies? | ||
| 01.06. | ASCO26: DNA test could spare breast cancer patients chemo | ||
| 01.06. | Lilly licenses Hanmi GLP-2 drug in $1.26bn deal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.